Semaphorin 3A – a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus

Osteoprotection by semaphorin 3A

(2012) Mikihito Hayashi et al.   NATURE

Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells

(2011) Aharon Kessel et al.   AUTOIMMUNITY REVIEWS

Disturbed Th1, Th2, Th17 and Treg balance in patients with systemic lupus erythematosus

(2011) Sebastian Dolff et al.   CLINICAL IMMUNOLOGY

Intranasal Administration of Semaphorin-3A Alleviates Sneezing and Nasal Rubbing in a Murine Model of Allergic Rhinitis

(2011) Haruna Sawaki et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

(2011) Sandra V Navarra et al.   LANCET

The involvement of immune semaphorins and neuropilin-1 in lupus nephritis

(2011) Z Vadasz et al.   LUPUS

Differences between rheumatologists and other internists regarding diagnosis and treatment of systemic lupus erythematosus

(2011) K. Lerang et al.   RHEUMATOLOGY

Neuropilins and semaphorins — from angiogenesis to autoimmunity

(2010) Z. Vadasz et al.   AUTOIMMUNITY REVIEWS

CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients

(2010) Paul A. Blair et al.   IMMUNITY

TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy

(2010) S.A. Summers et al.   JOURNAL OF AUTOIMMUNITY

IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients

(2010) Aharon Kessel et al.   JOURNAL OF CLINICAL IMMUNOLOGY

The Neuroimmune Semaphorin-3A Reduces Inflammation and Progression of Experimental Autoimmune Arthritis

(2010) A. Catalano   JOURNAL OF IMMUNOLOGY

Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients

(2010) Federica Capolunghi et al.   RHEUMATOLOGY

Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis

(2009) A. Henno et al.   BRITISH JOURNAL OF DERMATOLOGY

Galectin-1 and Semaphorin-3A Are Two Soluble Factors Conferring T-Cell Immunosuppression to Bone Marrow Mesenchymal Stem Cell

(2009) Yves Lepelletier et al.   STEM CELLS AND DEVELOPMENT

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

(2008) G Ruiz-Irastorza et al.   ANNALS OF THE RHEUMATIC DISEASES

Neuropilin-1 Expression on Regulatory T Cells Enhances Their Interactions with Dendritic Cells during Antigen Recognition

(2008) Milka Sarris et al.   IMMUNITY